{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:23:22Z","timestamp":1771651402486,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,6,21]],"date-time":"2009-06-21T00:00:00Z","timestamp":1245542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00296-009-0969-5","type":"journal-article","created":{"date-parts":[[2009,6,20]],"date-time":"2009-06-20T05:19:41Z","timestamp":1245475181000},"page":"357-363","source":"Crossref","is-referenced-by-count":120,"title":["Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis"],"prefix":"10.1007","volume":"30","author":[{"given":"Young Ho","family":"Lee","sequence":"first","affiliation":[]},{"given":"Jin-Hyun","family":"Woo","sequence":"additional","affiliation":[]},{"given":"Seong Jae","family":"Choi","sequence":"additional","affiliation":[]},{"given":"Jong Dae","family":"Ji","sequence":"additional","affiliation":[]},{"given":"Gwan Gyu","family":"Song","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,6,21]]},"reference":[{"key":"969_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(97)07226-7","volume":"350","author":"P Creamer","year":"1997","unstructured":"Creamer P, Hochberg MC (1997) Osteoarthritis. Lancet 350:503\u2013508","journal-title":"Lancet"},{"key":"969_CR2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/rheumatology\/kei171","volume":"45","author":"G Verbruggen","year":"2006","unstructured":"Verbruggen G (2006) Chondroprotective drugs in degenerative joint diseases. Rheumatology 45:129\u2013138","journal-title":"Rheumatology"},{"key":"969_CR3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/rheumatology\/kem026","volume":"46","author":"JY Reginster","year":"2007","unstructured":"Reginster JY, Bruyere O, Neuprez A (2007) Current role of glucosamine in the treatment of osteoarthritis. Rheumatology 46:731\u2013735","journal-title":"Rheumatology"},{"key":"969_CR4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1063-4584(03)00028-1","volume":"11","author":"R Largo","year":"2003","unstructured":"Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, Herrero-Beaumont G (2003) Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthr Cartil 11:290\u2013298","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl A","key":"969_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1063-4584(98)80004-6","volume":"6","author":"T Hardingham","year":"1998","unstructured":"Hardingham T (1998) Chondroitin sulfate and joint disease. Osteoarthr Cartil 6(Suppl A):3\u20135","journal-title":"Osteoarthr Cartil"},{"key":"969_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/sarh.2000.24874","volume":"31","author":"JP Bali","year":"2001","unstructured":"Bali JP, Cousse H, Neuzil E (2001) Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system. Semin Arthritis Rheum 31:58\u201368","journal-title":"Semin Arthritis Rheum"},{"key":"969_CR7","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/art.22728","volume":"56","author":"SC Vlad","year":"2007","unstructured":"Vlad SC, LaValley MP, McAlindon TE, Felson DT (2007) Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 56:2267\u20132277","journal-title":"Arthritis Rheum"},{"key":"969_CR8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-146-8-200704170-00009","volume":"146","author":"S Reichenbach","year":"2007","unstructured":"Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, Dieppe PA, Juni P (2007) Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 146:580\u2013590","journal-title":"Ann Intern Med"},{"key":"969_CR9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62:1145\u20131155","journal-title":"Ann Rheum Dis"},{"key":"969_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16:137\u2013162","journal-title":"Osteoarthr Cartil"},{"key":"969_CR11","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","volume":"162","author":"K Pavelka","year":"2002","unstructured":"Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC (2002) Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162:2113\u20132123","journal-title":"Arch Intern Med"},{"key":"969_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","volume":"357","author":"JY Reginster","year":"2001","unstructured":"Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C (2001) Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357:251\u2013256","journal-title":"Lancet"},{"key":"969_CR13","unstructured":"Kahan A, Reginster JY, Vignon E. STOPP (Study on Osteoarthritis Progression Prevention): a new two-year trial with chondroitin 4&6 sulfate (CS) [abstract]. EULAR 2006 June 23; Amsterdam, The Netherlands: Institut Biochimique SA (IBSA). Available at http:\/\/www.ibsa-ch.com\/welcome-head\/rd-symposia-past_events-2006-intl.htm?id=1439"},{"key":"969_CR14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.20867","volume":"52","author":"BA Michel","year":"2005","unstructured":"Michel BA, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, Uebelhart D (2005) Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum 52:779\u2013786","journal-title":"Arthritis Rheum"},{"key":"969_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","volume":"12","author":"D Uebelhart","year":"2004","unstructured":"Uebelhart D, Malaise M, Marcolongo R, de Vathaire F, Piperno M, Mailleux E, Fioravanti A, Matoso L, Vignon E (2004) Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage 12:269\u2013276","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl A","key":"969_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1063-4584(98)80011-3","volume":"6","author":"D Uebelhart","year":"1998","unstructured":"Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E (1998) Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthr Cartil 6(Suppl A):39\u201346","journal-title":"Osteoarthr Cartil"},{"key":"969_CR17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533\u20131537","journal-title":"BMJ"},{"key":"969_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"key":"969_CR19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"969_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000077386","volume":"57","author":"J Corbett","year":"2004","unstructured":"Corbett J, Gu CC, Rice JP, Reich T, Province MA, Rao DC (2004) Power loss for linkage analysis due to the dichotomization of trichotomous phenotypes. Hum Hered 57:21\u201327","journal-title":"Hum Hered"},{"key":"969_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"969_CR22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"969_CR23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/0003-4819-148-4-200802190-00005","volume":"148","author":"RM Rozendaal","year":"2008","unstructured":"Rozendaal RM, Koes BW, van Osch GJ, Uitterlinden EJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JA, Weinans H, Bierma-Zeinstra SM (2008) Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med 148:268\u2013277","journal-title":"Ann Intern Med"},{"key":"969_CR24","first-page":"1862","volume":"27","author":"T Conrozier","year":"1998","unstructured":"Conrozier T (1998) Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6). Presse Med 27:1862\u20131865 (French)","journal-title":"Presse Med"},{"key":"969_CR25","first-page":"31","volume":"24","author":"M Malaise","year":"1999","unstructured":"Malaise M, Marcolongo R, Ubelhart D, Vignon E (1999) Efficacy and tolerability of 800\u00a0mg oral chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: a randomized, double-blind, multicentre study versus placebo. Lit Rheumatol 24:31\u201342 (German)","journal-title":"Lit Rheumatol"},{"key":"969_CR26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard.57.10.624","volume":"57","author":"P Ravaud","year":"1998","unstructured":"Ravaud P, Giraudeau B, Auleley GR, Drape JL, Rousselin B, Paolozzi L, Chastang C, Dougados M (1998) Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis. Ann Rheum Dis 57:624\u2013629","journal-title":"Ann Rheum Dis"},{"key":"969_CR27","first-page":"1787","volume":"34","author":"TE Towheed","year":"2007","unstructured":"Towheed TE, Anastassiades T (2007) Glucosamine therapy for osteoarthritis: an update. J Rheumatol 34:1787\u20131790","journal-title":"J Rheumatol"},{"key":"969_CR28","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.163.13.1514","volume":"163","author":"F Richy","year":"2003","unstructured":"Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY (2003) Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 163:1514\u20131522","journal-title":"Arch Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-0969-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0969-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:16:17Z","timestamp":1559042177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-0969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,21]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-0969-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,21]]}}}